Learn more at LeadIQ.com

Insights

Clinical-Stage Lead Product 89bio's lead product candidate, BIO89-100, shows promising results for the treatment of NASH and SHTG, presenting a significant sales opportunity in the liver and cardio-metabolic disease treatment market.

Key Personnel Additions Recent high-profile hires like Teresa Perney, Francis Sarena, and Charles McWherter signify a strengthening leadership team, potentially opening doors for strategic partnerships and expanded sales channels.

Financial Health Boost With recent significant financings totaling $150M and investments from notable entities like Quest Partners LLC and Monashee Investment Management LLC, 89bio's financial stability creates a foundation for increased research, development, and potential sales growth.

Experienced Board Member The appointment of Martin Babler, a seasoned biopharmaceutical executive, as a Director, brings extensive industry know-how and networks, enhancing credibility and opening avenues for new business opportunities and partnerships.

Strategic Market Positioning Being in the biotechnology research industry alongside recognizable players like Acceleron Pharma and Abeona Therapeutics, 89bio's innovative therapies and focus on patient-first values create a unique positioning for targeted sales and collaborations within the competitive landscape.

Similar companies to 89bio

89bio Tech Stack

89bio uses 8 technology products and services including SAS, Cloudflare CDN, WordPress, and more. Explore 89bio's tech stack below.

SAS
Business Intelligence
Cloudflare CDN
Content Delivery Network
WordPress
Content Management System
TriNet
Human Resource Management System
IBM
Miscellaneous
Amazon Web Services
Platform As A Service
Python
Programming Languages
Bootstrap
UI Frameworks

Media & News

89bio's Email Address Formats

89bio uses at least 1 format(s):

89bio Email Formats	Example	Percentage
First.Last@89bio.com	John.Doe@89bio.com	50%
First.Last@89bio.com	John.Doe@89bio.com	50%

Frequently Asked Questions

Where is 89bio's headquarters located?

89bio's main headquarters is located at San Francisco, CA US. The company has employees across 4 continents, including North AmericaAsiaAfrica.

What is 89bio's stock symbol?

89bio is a publicly traded company; the company's stock symbol is ETNB.

What is 89bio's official website and social media links?

89bio's official website is 89bio.com and has social profiles on LinkedIn.

How much revenue does 89bio generate?

As of September 2024, 89bio's annual revenue reached $3.8M.

What is 89bio's SIC code NAICS code?

89bio's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does 89bio have currently?

As of September 2024, 89bio has approximately 112 employees across 4 continents, including North AmericaAsiaAfrica. Key team members include Chief Financial Officer: R. M.Chief Technical Operations Officer & Head Of Quality: Q. L.Vice President Regulatory Affairs: J. C.. Explore 89bio's employee directory with LeadIQ.

What industry does 89bio belong to?

89bio operates in the Biotechnology Research industry.

What technology does 89bio use?

89bio's tech stack includes SASCloudflare CDNWordPressTriNetIBMAmazon Web ServicesPythonBootstrap.

What is 89bio's email format?

89bio's email format typically follows the pattern of . Find more 89bio email formats with LeadIQ.

How much funding has 89bio raised to date?

As of September 2024, 89bio has raised $150M in funding. The last funding round occurred on Dec 06, 2023 for $150M.

When was 89bio founded?

89bio was founded in 2018.

89bio

89bio

Biotechnology ResearchCalifornia, United States51-200 Employees

89bio is a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardio-metabolic diseases. The company’s lead product candidate, BIO89-100, is a specifically engineered glycoPEGylated analog of FGF21. BIO89-100 is being developed for the treatment of nonalcoholic steatohepatitis (NASH) and severe hypertriglyceridemia (SHTG). Recent Phase 1b/2a data show BIO89-100 demonstrated a favorable safety and tolerability profile and robust reductions in liver fat and key lipid markers when dosed weekly or once every two weeks in patients with NASH. BIO89-100 is currently in a Phase 2 trial for the treatment of SHTG. 89bio is headquartered in San Francisco with operations in Herzliya, Israel.

Our culture is best described by our values:
•	Always putting the patient first
•	Operating with the highest integrity and ethical standards at all times
•	Being authentic in all our transactions
•	Acting as a team – collaborating, respecting and caring for one another
•	Being entrepreneurial and passionate in our tasks
•	Being scientific and rational in our thought process and decision-making

Company Overview

Headquarters: San Francisco, CA US
Website: 89bio.com
SIC Code: 8733 - Noncommercial Research Organizations
Stock Symbol: ETNB
NAICS Code: 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded: 2018
Employees: 51-200

Media & News

Funding & Financials

$150M
89bio has raised a total of $150M of funding over 7 rounds. Their latest funding round was raised on Dec 06, 2023 in the amount of $150M.
$10M
89bio's revenue is in the range of $10M

Funding & Financials

$150M
89bio has raised a total of $150M of funding over 7 rounds. Their latest funding round was raised on Dec 06, 2023 in the amount of $150M.
$10M
89bio's revenue is in the range of $10M

Company Leadership

R. M.
Chief Financial Officer
✕
Access Insights for 89bio and Millions of Other Companies
Sign up for full access to 89bio information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for 89bio and Millions of Other Companies
Sign up for full access to 89bio information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
Q. L.
Chief Technical Operations Officer & Head Of Quality
✕
Access Insights for 89bio and Millions of Other Companies
Sign up for full access to 89bio information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for 89bio and Millions of Other Companies
Sign up for full access to 89bio information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
J. C.
Vice President Regulatory Affairs
✕
Access Insights for 89bio and Millions of Other Companies
Sign up for full access to 89bio information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for 89bio and Millions of Other Companies
Sign up for full access to 89bio information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
J. C.
Vice President Regulatory Affairs
✕
Access Insights for 89bio and Millions of Other Companies
Sign up for full access to 89bio information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for 89bio and Millions of Other Companies
Sign up for full access to 89bio information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
S. J.
Vice President Cmc
✕
Access Insights for 89bio and Millions of Other Companies
Sign up for full access to 89bio information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for 89bio and Millions of Other Companies
Sign up for full access to 89bio information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email

Employee Directory

A. C.
Vice President, Investor Relations & Corporate Communications
✕
Access Insights for 89bio and Millions of Other Companies
Sign up for full access to 89bio information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for 89bio and Millions of Other Companies
Sign up for full access to 89bio information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
J. C.
Vice President Regulatory Affairs
✕
Access Insights for 89bio and Millions of Other Companies
Sign up for full access to 89bio information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for 89bio and Millions of Other Companies
Sign up for full access to 89bio information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
P. S.
Senior Vice President, R&d Operations
✕
Access Insights for 89bio and Millions of Other Companies
Sign up for full access to 89bio information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for 89bio and Millions of Other Companies
Sign up for full access to 89bio information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
G. C.
Interim Head Of Talent Acquisition (currently On Assignment)
✕
Access Insights for 89bio and Millions of Other Companies
Sign up for full access to 89bio information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for 89bio and Millions of Other Companies
Sign up for full access to 89bio information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
J. C.
Vice President Regulatory Affairs
✕
Access Insights for 89bio and Millions of Other Companies
Sign up for full access to 89bio information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for 89bio and Millions of Other Companies
Sign up for full access to 89bio information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email

Go to Employee Directory

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.